Predictors of Total Mortality and Echocardiographic Response for Cardiac Resynchronization Therapy: A Cohort Study

Guilherme Ferreira Gazzoni1,2, Matheus Bom Fraga1, Andres Di Leoni Ferrari1

  • 1Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) Porto Alegre, RS - Brazil.

Insights

Cardiac resynchronization therapy (CRT) success hinges on patient selection. This study identified age, COPD, and prior heart attack as mortality predictors, while biventricular pacing improved survival and response.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Medical Device Technology

Background:

  • Up to 40% of patients do not respond to cardiac resynchronization therapy (CRT).
  • Appropriate patient selection is critical for successful CRT in heart failure patients.
  • Understanding mortality predictors and response factors is essential for optimizing CRT outcomes.

Purpose of the Study:

  • To evaluate mortality predictors in patients undergoing CRT in Brazil.
  • To assess factors influencing echocardiographic response to CRT.
  • To identify patient subgroups who benefit most from CRT.

Main Methods:

  • Retrospective cohort study of 170 patients receiving CRT from 2008-2014.
  • Survival analysis using Cox regression and Kaplan-Meier curves.
  • Poisson regression for echocardiographic response predictors.

Main Results:

  • Overall mortality was 30% with independent predictors including age, prior acute myocardial infarction (AMI), and chronic obstructive pulmonary disease (COPD).
  • Higher percentage of biventricular stimulation at 6 months was protective against mortality (HR 0.97, p=0.048).
  • Echocardiographic response was associated with absence of mitral insufficiency, left bundle branch block, and percentage of biventricular stimulation.

Conclusions:

  • Mortality after CRT is independently linked to age, COPD, and previous AMI.
  • Biventricular pacing at 6 months post-implantation is associated with improved survival and echocardiographic response.
  • These findings highlight the importance of patient selection and pacing optimization for CRT efficacy.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
605
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539